The sphygmomanometer market has seen significant growth in recent years on account of increasing prevalence of cardiovascular diseases and rising awareness among people about monitoring their blood pressure regularly. A sphygmomanometer, commonly known as a blood pressure meter, is a device used to measure blood pressure non-invasively. It includes an inflatable cuff that is wrapped around the upper arm and a mercury or mechanical manometer to display the pressure readings in mmHg. Sphygmomanometers provide an essential diagnostic tool for healthcare professionals to detect hypertension and monitor patients at risk of heart attacks and strokes. The growing geriatric population base that is more susceptible to high blood pressure further amplifies the need for sphygmomanometers. Technological advancements have led to the development of digital, automated blood pressure monitors that are compact, portable and enable home monitoring.

The Global Sphygmomanometer Market is estimated to be valued at US$ 3.92 Bn in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the sphygmomanometer market are Omron Healthcare, ICU Medical Inc., Koninklijke Philips N.V., Baxter, Nihon Kohden, AD Medical, Spengler, SunTech Medical, Rudolf Riester GmbH, Microlife Corporation, American Diagnostic Corporation, Panasonic Healthcare, Beurer, Rossmax International Ltd., PAUL HARTMANN, BPL Medical Technologies, Homedics. Omron Healthcare maintains its leadership position with wide portfolio of upper arm, wrist, fingertip and forearm blood pressure monitors.

The growing prevalence of cardiovascular diseases and rising health awareness are fueling demand for self- monitoring devices. Home-use sSphygmomanometer Market Size provide convenience to users for measuring blood pressure regularly without visiting physician clinics or hospitals. Digital blood pressure monitors are gaining popularity due to their compact nature, accuracy and memory to store previous readings.

Manufacturers are expanding their footprint in emerging markets of Asia Pacific, Middle East and Latin America. These regions present lucrative opportunities for sphygmomanometer sales supported by growing medical infrastructure, increasing healthcare spending and rising disposable incomes. Several leading companies have set up production facilities and strengthened distribution networks in developing nations.

Market Drivers

Growing geriatric population - The risk of hypertension and cardiovascular issues increases with age. With rise in life expectancy across major countries, the elderly population acting as a consistent market for blood pressure monitoring devices.

Increasing awareness about benefits of regular monitoring - Health organizations and physicians emphasizing on importance of maintaining optimal blood pressure levels. This has boosted adoption of home-use digital sphygmomanometers for self-monitoring.

Rising prevalence of cardiovascular diseases - Conditions like heart attacks and strokes linked with hypertension are on the rise globally due to sedentary lifestyles and unhealthy diets. This substantiates need for sphygmomanometers.

Get more insights on - Sphygmomanometer Market

Explore Related Articles- Kidney Cancer Drugs Market